503A vs 503B Compounding Pharmacies: How to Verify Who Makes Your GLP-1 (2026)
How to find out which pharmacy compounds your semaglutide or tirzepatide, what 503A vs 503B means, and how to confirm a sterile-compounding license yourself in under five minutes.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This guide explains how to confirm who compounds your GLP-1, what the 503A and 503B frameworks mean, and how to verify a sterile-compounding license yourself, so you can evaluate any provider on facts rather than marketing.
Quick links: Compounded semaglutide $99/mo, compounded tirzepatide $125/mo, and is online compounding safe?
More on Compounded GLP-1 Safety and Legitimacy
Is Online Compounded Semaglutide & Tirzepatide Safe?
The full safety framework for compounded GLP-1.
Why Is Compounded Semaglutide So Cheap?
The economics behind $99 vs $900, without a quality compromise.
Cheapest Legal GLP-1 Online (2026)
How to spot a legitimate provider versus a red-flag price.
Your Pharmacy or Provider Shut Down? Continuity Guide
What to do if your compounded GLP-1 source closes mid-treatment.
You Have the Right to Know Who Makes Your Medication
When you inject a compounded GLP-1, the single most important quality question is not the price, it is who prepared the vial and under what license. A legitimate telehealth provider can name its compounding pharmacy and give you a state license number on request. If a provider will not tell you which facility fills your prescription, you cannot verify anything else about quality, and that opacity is itself the warning sign.
This has become the question patients ask most as the market matured through 2025 and 2026. The good news: verifying a pharmacy is something you can do yourself in a few minutes using free, public state board databases. This guide walks through the 503A versus 503B distinction, how to confirm a license, the named-pharmacy questions patients raise in communities like r/tirzepatidecompound, and the specific red flags that should make you walk away.
"Consumers should always know which pharmacy is filling their prescription. Prices that are too low, and pharmacies that don't ask for a prescription, should trigger alarm bells."— Betty Jones, National Association of Boards of Pharmacy (NABP), via NPR, 2025
The one-sentence version: A trustworthy compounded-GLP-1 provider will (1) name its pharmacy, (2) give you a state license number, (3) confirm USP <797> sterile compliance, and (4) provide per-batch testing on request. Trimi answers yes to all four, VialsRx (Texas license #35264) and GreenwichRx.
503A vs 503B: What the Two Frameworks Actually Mean
Compounding in the United States is governed by the Federal Food, Drug, and Cosmetic Act as amended by the Drug Quality and Security Act of 2013. It defines two categories of compounding pharmacy, and both are legitimate paths for compounded GLP-1 medications. The difference is in scale and oversight model, not in whether the medication can be safe.
| Factor | 503A (community sterile pharmacy) | 503B (outsourcing facility) |
|---|---|---|
| Prescription model | Patient-specific prescription required | Can compound in batches without a patient-specific prescription |
| Primary oversight | State board of pharmacy + USP <797> | FDA-registered + cGMP, FDA-inspected |
| Typical volume | Individualized, smaller batches | Larger-scale production |
| GLP-1 status (2026) | Primary pathway for patient-specific compounded GLP-1 | Narrowed after the shortage list closed |
| What to verify | Active state license, sterile classification, USP <797> | FDA registration number, inspection history |
Neither category is automatically safer. A disciplined 503A community sterile pharmacy that names itself, holds an active license, and tests every batch can be every bit as safe as a 503B, and a 503B you cannot identify gives you nothing to verify. After the FDA removed semaglutide and tirzepatide from the shortage list, patient-specific compounding under the 503A pathway became the typical route for compounded GLP-1. Trimi partners with state-licensed 503A community sterile compounding pharmacies for exactly this reason.
How to Verify a Pharmacy Yourself in Five Minutes
You do not need to take a provider's word for it. Every state board of pharmacy maintains a free public license-lookup tool. Here is the exact process:
Get the pharmacy name and license number
Ask your provider in writing. A legitimate one answers without hesitation, e.g., 'VialsRx, Texas license #35264.'
Open the state board of pharmacy lookup
Search '[state] board of pharmacy license verification.' Use the state where the pharmacy operates, not where you live.
Confirm the license is active
Check the status and expiration date. An active, unexpired license is the baseline.
Confirm the sterile-compounding classification
Verify the license covers sterile compounding (Low/Medium risk is appropriate for GLP-1 injectables, see the next section).
Check for disciplinary orders
Most boards list any disciplinary actions. A clean record is what you want to see.
Ask for a certificate of analysis (COA)
Request third-party batch testing for potency, purity, and sterility. A quality provider supplies it on request.
The "Sterile-Risk Classification" Question, Explained
A recurring misconception in compounded-GLP-1 communities is that a pharmacy needs a "High-Risk" sterile classification to compound semaglutide or tirzepatide. That is not how USP <797> works. The risk level describes the starting components, not the medication.
Under USP <797>, High-Risk compounding refers to preparing a sterile product from non-sterile starting materials. Compounding an injectable from sterile, pharmaceutical-grade semaglutide or tirzepatide API qualifies as Medium-Risk sterile compounding. A pharmacy licensed for Low- and Medium-Risk sterile compounding is appropriately licensed for GLP-1 injectables, a "High-Risk" designation is not required for this work.
For Trimi's primary partner specifically: VialsRx holds Texas State Board of Pharmacy license #35264, with sterile compounding at the Low- and Medium-Risk levels appropriate to this preparation. Per the public Texas board record, the license is active through 02/29/2028 with no prior disciplinary orders, and the pharmacist-in-charge has been registered since 1975. You can confirm all of this yourself by searching license #35264 on the Texas State Board of Pharmacy website, which is exactly the kind of independent verification this guide encourages.
Named-Pharmacy Questions Patients Ask
In communities like r/tirzepatidecompound and r/CompoundedSemaglutide, patients increasingly compare specific pharmacy names, BPI, Hallandale, Empower, VialsRx, and others, before trusting a provider. That instinct is correct: the name is what lets you verify everything else. The takeaway is not that one named pharmacy is universally best, but that a provider unwilling to give you any name has failed the most basic transparency test.
Use the same checklist for any pharmacy name you are given: active license, sterile classification, USP <797> compliance, clean disciplinary record, and testing on request. A disclosed pharmacy with a minor, resolved compliance note is a better sign than a provider who discloses nothing at all, because disclosure is what makes verification possible.
Red Flags That Should Make You Walk Away
- The provider will not name the pharmacy or 'can't share it for competitive reasons.'
- No state license number is offered, or the number does not check out on the board's site.
- You can pay and get a prescription without any medical evaluation (click-to-buy).
- No mention of USP <797>, batch testing, or certificates of analysis.
- A price far below the legitimate market with no named pharmacy behind it.
- Products sold as 'research chemicals,' 'not for human use,' or shipped from overseas without a US prescription.
Price skepticism is healthy, but price alone is the wrong filter. A low price with full pharmacy disclosure, licensing, and testing is legitimate value; a low price with no named pharmacy is a risk. For more on why a transparent provider can be both affordable and safe, see why compounded semaglutide is so cheap.
How Trimi Handles This
Trimi is built to pass its own checklist. It names both compounding partners publicly, VialsRx (Texas State Board of Pharmacy license #35264) and GreenwichRx, state-licensed 503A community sterile compounding pharmacies operating under USP <797>. Documentation of pharmacy licensing and per-batch potency, purity, and sterility testing is available on request.
Every prescription is written by a US-licensed provider through the Arora Health 50-state network after a required medical evaluation, never a click-to-buy checkout. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month on the annual plan, all-inclusive, with the same active ingredient used in the brand-name products. To start, see compounded semaglutide or compounded tirzepatide. If your current source has closed, see our pharmacy shutdown continuity guide.
Frequently Asked Questions
What is the difference between a 503A and a 503B compounding pharmacy?
A 503A pharmacy compounds a medication for a specific, named patient against an individual prescription, under state board of pharmacy oversight and the USP <797> sterile-compounding standard. A 503B outsourcing facility is FDA-registered, follows current Good Manufacturing Practice (cGMP), is inspected by the FDA like a drug manufacturer, and can produce batches without a patient-specific prescription. Both are legal frameworks for compounded GLP-1 medications. The right question is not '503A or 503B' alone, but whether the pharmacy is licensed, named, and tests every batch.
Is a 503A or 503B pharmacy safer for compounded semaglutide?
Neither category is automatically safer. A well-run 503A community sterile pharmacy with third-party batch testing can be as safe as a 503B, and a 503B is not safe if it is unnamed or unlicensed. After the FDA shortage list closed, patient-specific compounded tirzepatide and semaglutide are typically prepared under the 503A pathway. What matters is verifiable quality: a named pharmacy, an active state license, USP <797> compliance, and per-batch potency, purity, and sterility testing you can request.
How do I find out which pharmacy actually makes my compounded GLP-1?
Ask your telehealth provider directly: 'Which pharmacy fills my prescription, and what is its state board license number?' A legitimate provider answers in writing without hesitation. If they refuse, cite 'competitive reasons,' or cannot give you a name and license number, treat that as a red flag. You have a right to know which licensed facility prepares a medication you inject. Trimi names its partners publicly: VialsRx (Texas license #35264) and GreenwichRx.
What is USP <797> and why does it matter?
USP General Chapter <797> is the United States Pharmacopeia standard governing sterile compounding, the clean-room conditions, air quality, personnel technique, and beyond-use dating required to prepare an injectable safely. Any pharmacy compounding an injectable GLP-1 must comply with <797>. It is the baseline that protects against contamination. When you evaluate a provider, confirm its pharmacy partner is USP <797> compliant for sterile preparations.
Does a pharmacy need a 'High-Risk' sterile classification to compound semaglutide or tirzepatide?
No. This is a common misconception. Under USP <797>, the risk level reflects the starting components, not the drug. Compounding an injectable from sterile, pharmaceutical-grade semaglutide or tirzepatide API qualifies as Medium-Risk sterile compounding. High-Risk classification applies when compounding begins from non-sterile starting materials. A pharmacy licensed for Low- and Medium-Risk sterile compounding is appropriately licensed to prepare GLP-1 injectables; a 'High-Risk' designation is not required for this work.
How can I verify a compounding pharmacy's license myself?
Every state board of pharmacy publishes a public license-lookup database. Search the pharmacy name or license number on the board's website for the state where the pharmacy operates, and confirm the license is active, the classification covers sterile compounding, and there are no open disciplinary orders. For VialsRx, search the Texas State Board of Pharmacy for license #35264. The lookup takes a few minutes and is the single most useful verification step a patient can do.
Which pharmacies does Trimi use, and can I see their testing?
Trimi partners with two state-licensed 503A community sterile compounding pharmacies: VialsRx (Texas State Board of Pharmacy license #35264) and GreenwichRx. Both compound under USP <797> standards. Trimi provides documentation of pharmacy licensing and per-batch testing results on request, and every prescription is written by a US-licensed provider through the Arora Health 50-state network after a required medical evaluation.
Sources & References
- USP General Chapter <797>, Pharmaceutical Compounding: Sterile Preparations.
- FDA: Compounding and the FDA, Questions and Answers (503A and 503B).
- Texas State Board of Pharmacy, public license verification.
- NABP compounding pharmacy accreditation overview.
- FDA drug shortage database.
- NPR: Patients seeking cheaper weight-loss drugs online find questionable products — NABP guidance on verifying which pharmacy fills your prescription, 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical, legal, or regulatory advice. Compounded medications are prepared per individual prescription and are not FDA-approved as drugs; the active ingredients (semaglutide, tirzepatide) are FDA-approved in commercial formulations such as Wegovy, Ozempic, Zepbound, and Mounjaro. GLP-1 medications can cause side effects including nausea and, less commonly, pancreatitis, gallbladder disease, and kidney injury, and carry a boxed warning for thyroid C-cell tumors based on rodent studies; discuss your medical history with a licensed provider. Pharmacy licensing details and the regulatory status of compounded medications can change, confirm current information with the relevant state board and your provider. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.